Skip to content
Search

Latest Stories

International Nurses Day: Report shows the poorest regions face 70% shortages of nurses

A striking imbalance in nurse distribution persists

Global Nursing Inequality Exposed in New Report on Nurses Day

The WHO forecasts a continued reduction in the global nursing shortage

iStock

The global nursing workforce has grown by nearly two million over the past five years, yet major disparities in distribution continue to impede progress towards universal health coverage (UHC) and global health goals, according to the State of the World’s Nursing 2025 report released on 12 May by the World Health Organization (WHO), International Council of Nurses (ICN), and partners.

As of 2023, there are 29.8 million nurses worldwide, up from 27.9 million in 2018. The report also notes a decline in the global nursing shortage, from 6.2 million in 2020 to 5.8 million in 2023. However, the report cautions that the improvements are not evenly shared across regions and income levels, leaving many low- and middle-income countries struggling with persistent shortfalls.


A striking imbalance in nurse distribution persists: 78 per cent of the world’s nurses are based in countries that account for just 49 per cent of the global population. High-income nations host nearly half the global nursing workforce, despite representing only 17 per cent of the world’s population. This concentration has raised concerns that many countries are being left behind, particularly in Africa and the Eastern Mediterranean, where shortages are expected to remain critical.

The WHO forecasts a continued reduction in the global nursing shortage, projecting a shortfall of 4.1 million by 2030. However, almost 70 per cent of this gap is expected to be concentrated in the African and Eastern Mediterranean regions, which could seriously undermine healthcare delivery and preparedness for future health emergencies.

Low-income countries are seeing faster growth in nurse graduate numbers, yet many face challenges in translating this into increased nurse availability. Factors such as rapid population growth, limited job creation, and restricted resources mean these countries are unable to retain and integrate newly qualified nurses into the workforce. The report urges governments to prioritise domestic investment in health systems to ensure graduate absorption and improve employment conditions.

Meanwhile, high-income countries are experiencing a demographic shift in their nursing workforce. Around 19 per cent of nurses globally are expected to retire within the next decade. In some high-income nations, retirements are likely to exceed new entrants, raising the risk of workforce gaps and reduced mentoring capacity for younger nurses.

International migration continues to play a key role in shaping nursing workforces. Globally, one in seven nurses is foreign-born, with high-income countries depending on international recruitment for nearly a quarter of their workforce. By contrast, foreign-born nurses make up only 1–8 per cent of the workforce in lower-income countries. The report calls for stronger bilateral agreements to ensure ethical recruitment and mutual benefits for both source and destination countries.

Gender equity remains a central concern. Women comprise 85 per cent of the global nursing workforce, yet opportunities for advancement and leadership remain limited in many settings. While 82 per cent of countries report having a senior government nursing officer, only 25 per cent of low-income countries offer structured leadership development programmes for nurses.

The report also highlights progress in recognising advanced nursing roles, with 62 per cent of countries now reporting the existence of such positions, up from 53 per cent in 2020. Advanced practice nurses have been shown to enhance access to care, particularly in underserved areas.

Mental health and wellbeing support for nurses remains inadequate. Despite increased workloads and stress during the COVID-19 pandemic, only 42 per cent of countries surveyed have formal provisions for mental health support. The lack of such measures is seen as a barrier to retaining experienced staff and ensuring quality care.

The State of the World’s Nursing 2025 report sets out key policy recommendations for the 2026–2030 period. These include expanding and equitably distributing nursing jobs, aligning education systems with workforce needs, improving pay and working conditions, and strengthening regulation and leadership. Additional priorities focus on preparing nurses for digital healthcare delivery, addressing gender pay gaps, and supporting those working in conflict zones and climate-affected areas.

Pam Cipriano, President of the ICN, said the report served as an “important milestone” in tracking global efforts to strengthen nursing. “Delivering on UHC depends on recognising the true value of nurses and empowering them to lead health system improvements,” she said.

WHO Director-General Dr Tedros Adhanom Ghebreyesus welcomed the progress but warned that deep inequalities persist. “This report is a guide to where we are and what we must do next,” he said. “Countries must act quickly to close the gaps and support the nursing workforce.”

The report draws on data from 194 countries and is part of WHO’s efforts to monitor and strengthen the global health workforce as part of the push to meet the Sustainable Development Goals by 2030.

More For You

weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
Weight Loss Drug

Health officials expect the rollout to benefit around 220,000 adults over the next 3 years

iStock

NHS GPs to prescribe Mounjaro in nationwide obesity treatment plan

Key points

  • NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
  • The programme aims to support 220,000 people over three years
  • Eligible patients must have a BMI over 40 and at least four obesity-related health issues
  • GP leaders raise concerns over increased workload
  • Pharmacists urge a broader weight management approach

NHS expands obesity treatment with Mounjaro

The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.

Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.

Keep ReadingShow less
UK heatwave deaths

Around 85% of the projected deaths are likely to involve people over the age of 65

iStock

Scientists warn current UK heatwave may cause nearly 600 early deaths

Almost 600 premature deaths are expected to occur during the ongoing heatwave affecting England and Wales, according to a new rapid analysis by leading scientists. The majority of fatalities are projected among older adults, with London and the West Midlands likely to be the worst-affected areas.

Climate change driving deadly temperatures

Researchers say the extreme temperatures, which have reached 32°C in parts of south-east England, would have been nearly impossible without the influence of human-caused climate change. Pollution from burning fossil fuels has raised the likelihood of such heatwaves by around 100 times, experts say.

Keep ReadingShow less
Amycretin

'The Lancet' and presentations at the American Diabetes Association’s 2025

iStock

New weight-loss pill Amycretin shows greater impact than jabs, study finds

A new weight-loss drug, amycretin, has delivered the most significant results yet for appetite-suppressing GLP-1 medications, according to two newly published studies in The Lancet and presentations at the American Diabetes Association’s 2025 Scientific Sessions in Chicago.

Record weight loss from Amycretin injections

Researchers found that participants receiving high-dose weekly injections of amycretin lost 24.3 per cent of their body weight over 36 weeks. This outcome surpasses the results seen in longer trials involving other GLP-1 drugs such as tirzepatide (sold as Mounjaro), which previously led the field with an average weight loss of 20 per cent over 72 weeks.

Keep ReadingShow less
Hulk Hogan

Hogan’s current hospital stay follows a neck fusion surgery he underwent in May 2025

Getty Images

Hulk Hogan hospitalised for back and neck issues, rep confirms he is not on deathbed

WWE Hall of Famer Hulk Hogan has been hospitalised for ongoing neck and back issues, but representatives have confirmed he is not in critical condition, dismissing online speculation suggesting otherwise.

The 71-year-old wrestling icon, whose real name is Terry Bollea, was reported by TMZ Sports to be undergoing treatment related to injuries sustained during his decades-long in-ring career. His representative said Hogan is already mobile again and “not on his deathbed”, following false claims made on air by Florida radio personality Bubba the Love Sponge.

Keep ReadingShow less